Huang, D. Q., Tran, A., Yeh, M., Yasuda, S., Tsai, P., Huang, C., . . . Nguyen, M. H. (2023). Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase. Hepatology (Baltimore, Md.), 78(5), 1558-1568. https://doi.org/10.1097/HEP.0000000000000459
Citace podle Chicago (17th ed.)Huang, Daniel Q., et al. "Antiviral Therapy Substantially Reduces HCC Risk in Patients with Chronic Hepatitis B Infection in the Indeterminate Phase." Hepatology (Baltimore, Md.) 78, no. 5 (2023): 1558-1568. https://doi.org/10.1097/HEP.0000000000000459.
Citace podle MLA (9th ed.)Huang, Daniel Q., et al. "Antiviral Therapy Substantially Reduces HCC Risk in Patients with Chronic Hepatitis B Infection in the Indeterminate Phase." Hepatology (Baltimore, Md.), vol. 78, no. 5, 2023, pp. 1558-1568, https://doi.org/10.1097/HEP.0000000000000459.